Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
XERS Transcript
Xeris Biopharma Holdings, Inc. (XERS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Neutral3-11
Xeris Biopharma Holdings, Inc. (XERS) Q4 2025 Earnings Call Transcript
Positive3-2
The earnings call shows strong financial performance with a 15% revenue increase and a shift from net loss to net income. Improved gross margins and cash flow further support a positive outlook. Despite risks in forward-looking statements, the raised revenue guidance and strategic investments indicate confidence in future growth. These factors suggest a positive stock price movement in the short term.
Zurich Insurance Group AG (ZUR:CA) Q3 2025 Earnings Call Transcript
Positive11-6
The earnings call presents a positive outlook with raised revenue guidance, strong product performance, improved gross margin, and positive adjusted EBITDA. The Q&A section reinforces this sentiment with positive rate developments and growth strategies. Despite some management vagueness, the overall tone is optimistic, indicating potential stock price appreciation.
Xeris Biopharma Holdings, Inc. (XERS) Q3 2025 Earnings Call Transcript
Positive11-6
The earnings call indicates strong financial performance with raised revenue guidance and a significant increase in Recorlev revenue. Despite increased expenses, the company maintains positive adjusted EBITDA and achieved net income for the first time, highlighting operational strength. The Q&A reinforces confidence in Recorlev's growth potential and market expansion, with no major competitive threats identified. These factors suggest a positive stock price movement over the next two weeks.
XERS Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
